{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:32:47Z","timestamp":1786480367302,"version":"build-2736575974"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:00:00Z","timestamp":1766707200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2021-NR061375"],"award-info":[{"award-number":["RS-2021-NR061375"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["DIRAMS 51101-2021"],"award-info":[{"award-number":["DIRAMS 51101-2021"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.bbrc.2025.153204","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T16:48:15Z","timestamp":1766508495000},"page":"153204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["SLC16A3 as a novel therapeutic target for overcoming radioresistance and chemoresistance in lung cancer"],"prefix":"10.1016","volume":"797","author":[{"given":"Hye Min","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Ji","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Geun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wol Soon","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Uk","family":"Kye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HyoJin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeong-Rok","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3574-7668","authenticated-orcid":false,"given":"Seung Jin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3743-6881","authenticated-orcid":false,"given":"Sang-Gu","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong-Hwa","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2025.153204_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbrc.2025.153204_bib2","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000032899","article-title":"Non-small cell lung cancer (NSCLC): a review of risk factors, diagnosis, and treatment","volume":"102","author":"Alduais","year":"2023","journal-title":"Medicine (Baltim)."},{"key":"10.1016\/j.bbrc.2025.153204_bib3","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0025-6196(11)60735-0","article-title":"Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship","volume":"83","author":"Molina","year":"2008","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.bbrc.2025.153204_bib4","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.3390\/cancers14194562","article-title":"Current landscape of therapeutic resistance in lung cancer and promising strategies to overcome resistance","volume":"14","author":"Ashrafi","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.bbrc.2025.153204_bib5","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12943-023-01801-2","article-title":"Molecular mechanisms of tumor resistance to radiotherapy","volume":"22","author":"Wu","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbrc.2025.153204_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.218","article-title":"Metabolic reprogramming in cancer: mechanisms and therapeutics","volume":"4","author":"Nong","year":"2023","journal-title":"MedComm"},{"key":"10.1016\/j.bbrc.2025.153204_bib7","doi-asserted-by":"crossref","first-page":"952","DOI":"10.2174\/187152009789377682","article-title":"Apoptosis and apoptosis-based therapy in lung cancer","volume":"9","author":"Xu","year":"2009","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.bbrc.2025.153204_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semcancer.2023.01.007","article-title":"Targeting monocarboxylate transporters (MCTs) in cancer: how close are we to the clinics?","volume":"90","author":"Singh","year":"2023","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbrc.2025.153204_bib9","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3119375","article-title":"Tumor microenvironment: lactic acid promotes tumor development","author":"Gao","year":"2022","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.bbrc.2025.153204_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.932055","article-title":"Lactate from the tumor microenvironment: a key obstacle in NK cell-based immunotherapies","volume":"13","author":"Jedli\u010dka","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2025.153204_bib11","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.3390\/molecules30081763","article-title":"Tumor microenvironment lactate: is it a cancer progression marker, immunosuppressant, and therapeutic target?","volume":"30","author":"Kim","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.bbrc.2025.153204_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216837","article-title":"The emerging role of lactate in tumor microenvironment and its clinical relevance","volume":"590","author":"Chen","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2025.153204_bib13","doi-asserted-by":"crossref","DOI":"10.1080\/19336950.2023.2273008","article-title":"A systemic analysis of monocarboxylate transporters in ovarian cancer and possible therapeutic interventions","volume":"17","author":"Chatterjee","year":"2023","journal-title":"Channels (Austin)"},{"key":"10.1016\/j.bbrc.2025.153204_bib14","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.12659\/MSM.912272","article-title":"Monocarboxylate transporter 4 (MCT4) overexpression is correlated with poor prognosis of osteosarcoma","volume":"25","author":"Liu","year":"2019","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.bbrc.2025.153204_bib15","article-title":"Integrative analysis identified MCT4 as an independent prognostic factor for bladder cancer","volume":"11","author":"Zhao","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbrc.2025.153204_bib16","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/15384047.2016.1139232","article-title":"Radiotherapy diagnostic biomarkers in radioresistant human H460 lung cancer stem-like cells","volume":"17","author":"Yun","year":"2016","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.bbrc.2025.153204_bib17","article-title":"Mechanisms and perspective treatment of radioresistance in non-small cell lung cancer","volume":"14","author":"Zhou","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2025.153204_bib18","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.3390\/ijms23147594","article-title":"MicroRNAs as predictors of lung-cancer resistance and sensitivity to cisplatin","volume":"23","author":"Konoshenko","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2025.153204_bib19","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12935-023-02990-y","article-title":"Recent advances in non-small cell lung cancer targeted therapy: an update review","volume":"23","author":"Araghi","year":"2023","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbrc.2025.153204_bib20","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.cell.2017.09.019","article-title":"Lactate metabolism in human lung tumors","volume":"171","author":"Faubert","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2025.153204_bib21","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1172\/JCI69741","article-title":"Targeting lactate metabolism for cancer therapeutics","volume":"123","author":"Doherty","year":"2013","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbrc.2025.153204_bib22","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41392-024-02082-x","article-title":"Lactate and lactylation in cancer","volume":"10","author":"Chen","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.bbrc.2025.153204_bib23","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41392-023-01705-z","article-title":"Targeting the RAS\/RAF\/MAPK pathway for cancer therapy: from mechanism to clinical studies","volume":"8","author":"Bahar","year":"2023","journal-title":"Signal Transduct. Targeted Ther."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25019205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25019205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:15:20Z","timestamp":1786479320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X25019205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":23,"alternative-id":["S0006291X25019205"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.153204","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SLC16A3 as a novel therapeutic target for overcoming radioresistance and chemoresistance in lung cancer","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.153204","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"153204"}}